Tech Company Financing Transactions
Drug Farm Funding Round
Drug Farm, based in Shanghai, secured $55 million from Pudong Innotek and BioVeda Capital.
Transaction Overview
Company Name
Announced On
7/14/2026
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series D
Investors
Pudong Innotek (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the continued advancement ofits clinical and preclinical stage pipeline, accelerate global clinical development programs, strengthen regulatory activities across key markets, and further expand its research and development capabilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
69 Yuanfeng Road, Baoshan District
Shanghai, 200444
China
Shanghai, 200444
China
Phone
Undisclosed
Website
Email Address
Overview
Drug Farm builds unique platforms to develop innovative treatments for infection and immunological diseases. Drug Farm's IDInVivo? platform allows utlilizing genetic screens to directly identify novel drug targets in living animals with intact immune systems. Drug Farm's MedChem5 platform harnesses the power of deep learning technologies to accelerate first-in-class drugs development. Combining IDInVivo? and MedChem5 platforms, Drug Farm has identified novel immunity targets and developed first-in-class drug candidates reaching clinical stage.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 7/14/2026: Chai Discovery venture capital transaction
Next: 7/14/2026: Draig Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. VC investment data records on this site come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








